EUVIMEDEUVIMED entdecken
Crossref

Fabrication of a decellularized liver matrix–based hepatic patch for the repair of CCl4‐induced liver injury

Ting-Yi Wu, Yi-Cheng Hsieh, Wei-Rong Yin, Kai-Yi Cheng, Yung-Te Hou iD

Biotechnology Journal · 2024

DOI: 10.1002/biot.202300570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Ting-Yi Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomechatronics Engineering, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Carbon Tetrachloride, Liver, Hepatocyte Growth Factor, Heparin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Taiwan University Hospital and National Taiwan University, National Taiwan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article primarily introduces a new treatment for liver fibrosis/cirrhosis. We developed a hepatic patch by combining decellularized liver matrix (DLM) with the hepatocyte growth factor (HGF)/heparin–complex and evaluated its restorative efficacy. In vitro prophylactic results, the HGF/heparin–DLM patches effectively mitigated CCl 4 ‐induced hepatocyte toxicity and restored the cytotoxicity levels to the baseline levels by day 5. Furthermore, these patches restored albumin synthesis of injured hepatocytes to more than 70% of the normal levels within 5 days. In vitro therapeutic results, the urea synthesis of the injured hepatocytes reached 91% of the normal levels after 10 days of culture, indicating successful restoration of hepatic function by the HGF/heparin–DLM patches in both prophylactic and therapeutic models. In vivo results, HGF/heparin–DLM patches attached to the liver and gut exhibited a significant decrease in collagen content (4.44 times and 2.77 times, respectively) and an increase in glycogen content (1.19 times and 1.12 times, respectively) compared to the fibrosis group after 1 week, separately. In summary, liver function was restored and inflammation was inhibited through the combined effects of DLM and the HGF/heparin–complex in fibrotic liver. The newly designed hepatic patch holds promise for both in vitro and in vivo regeneration therapy and preventive health care for liver tissue engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon TetrachlorideLiverHepatocyte Growth FactorHeparinHepatocytesAnimalsMaleExtracellular MatrixTissue EngineeringMiceRatsLiver CirrhosisChemical and Drug Induced Liver InjuryHumansTissue ScaffoldsRats, Sprague-Dawley

Stichwörter der Autor:innen

CCl4decellularized liver matrixhepatocyte growth factor/heparin–complexliver fibrosisliver regeneration

Substanzen

Carbon TetrachlorideHepatocyte Growth FactorHeparin

Autor:innen und Institutionen

  • Department of Biomechatronics Engineering, National Taiwan University, Taipei, Taiwan.

ORCID-Profile: Yung-Te Hou

Förderung

  • National Taiwan University Hospital and National Taiwan University
  • National Taiwan University

Zitieren

APA

Wu, T. Y., Hsieh, Y. C., Yin, W. R., Cheng, K. Y., & Hou, Y. T. (2024). Fabrication of a decellularized liver matrix–based hepatic patch for the repair of CCl4‐induced liver injury. Biotechnology Journal. https://doi.org/10.1002/biot.202300570

Vancouver

Wu TY, Hsieh YC, Yin WR, Cheng KY, Hou YT. Fabrication of a decellularized liver matrix–based hepatic patch for the repair of CCl4‐induced liver injury. Biotechnology Journal. 2024. doi:10.1002/biot.202300570

BibTeX
@article{Wu2024,
  author = {Wu, Ting-Yi and Hsieh, Yi-Cheng and Yin, Wei-Rong and Cheng, Kai-Yi and Hou, Yung-Te},
  title = {Fabrication of a decellularized liver matrix–based hepatic patch for the repair of CCl4‐induced liver injury},
  journal = {Biotechnology Journal},
  year = {2024},
  doi = {10.1002/biot.202300570}
}
Kostenlos starten →